Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 35Pancreatic Fistula 4Pancreatic Ductal Adenocarcinoma 2Bile Duct Neoplasms 2Recurrence 1Peritoneal Diseases 1Periampullary Cancer 1Pancreatitis, Chronic 1Pancreatic Adenocarcinoma 1Obesity 1Neoplasm Metastasis 1Metabolic Syndrome 1Locally Advanced Pancreatic Adenocarcinoma 1Jaundice, Obstructive 1Hypoxia 1Hemorrhage 1Gastrointestinal Stromal Tumor of Duodenum 1Diabetes Mellitus 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Adenocarcinoma 1

Interventions

Gemcitabine 2spartalizumab 1sargramostim 1folfirinox 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Pancreaticoduodenectomy 1Magnetic Resonance Spectroscopy 1Leucovorin 1Laparoscopy 1Fluorouracil 1Drug Therapy 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Pancreatic Adenocarcinoma × Pancreaticoduodenectomy × Gastrointestinal × Clear all
NCT06132087 2025-11-25

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

University of Southern California

Phase NA Active not recruiting
2 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡